HighTower Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

HighTower Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-126,815	Closed	-$2.15M	–	1764
2014 Q4	$2.15M	Sell	126,815 -70,878	-36%	-$997K	0.03%	558
2014 Q3	$2.31M	Sell	197,693 -2,010	-1%	-$13.7K	0.04%	505
2014 Q2	$1.13M	Buy	199,703 +14,408	+8%	+$66.4K	0.02%	766
2014 Q1	$680K	Buy	185,295 +61,760	+50%	+$235K	0.01%	872
2013 Q4	$415K	Buy	+123,535	New	+$510K	0.01%	1038

HighTower Advisors's AVNR Position: Q1 2015 in Review

HighTower Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 126,815 shares — an estimated $2.15M sold.

HighTower Advisors first reported a position in AVNR in Q4 2013 and held it in 5 quarters. The position peaked at $2.31M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

HighTower Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
HighTower Advisors sold 126,815 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.15M.
HighTower Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2013 and held it in 5 quarters.
HighTower Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.31M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on HighTower Advisors's 13F filing for Q1 2015, filed 15 May 2015.